Diabetes Drug May Increase Risk For Leg And Foot Amputations: FDA

Results of an ongoing clinical trial show a potential danger of using Canagliflozin, which is sold under the brand names Invokana and Invokamet. The diabetes drug has been linked with increased risk for foot and leg amputations.